Disease Info Card

Oropharyngeal Disorders

Information about Oropharyngeal Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Oropharyngeal Disorders

Most recent studies have shown that Oropharyngeal Disorders shares some biological mechanisms with candidiasis, carcinoma, deglutition-disorders, head-and-neck-neoplasms, hiv-infections, infective-disorder, malignant-head-and-neck-neoplasm, malignant-neck-neoplasm, malignant-neoplasm-of-oropharynx, malignant-neoplasms, malignant-squamous-cell-neoplasm, mouth-neoplasms, neoplasm-metastasis, neoplasms, oral-candidiasis, oropharyngeal-candidiasis, oropharyngeal-neoplasms, oropharyngeal-squamous-cell-carcinoma, pharyngeal-neoplasms, pneumonia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Oropharyngeal Disorders, and have been seen in publications frequently: Aging, Cell Cycle, Cell Proliferation, Dehiscence, Drug Resistance, Excretion, Hypersensitivity, Immune Response, Inflammatory Response, Innervation, Localization, Mastication, Pathogenesis, Peristalsis, Reflex, Reverse Transcription, Secretion, Transport, Virulence, Wound Healing

Quite a number of genes have been found to play important roles in Oropharyngeal Disorders, such as ACAT1, ALB, ARSA, AVP, CALR, CAT, CD4, CDKN2A, COPA, CSF2, EGFR, MID1, NDUFB6, POMT1, RANGAP1, SERPINB3, SLC17A5, SLC25A5, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.